$4.67
-0.25-5.08%
Last update: Nov 12, 9:28 AM
Alvotech (ALVO) Stock Price, Quote, News & History
ALVONASDAQ
Alvotech shares decline after the FDA issues a complete response letter for its Simponi biosimilar, leading to a lower 2025 revenue and EBITDA outlook.
You can purchase shares of Alvotech (NASDAQ:ALVO) through any online brokerage.
Other companies in Alvotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Alvotech has a consensus price target of $10.50.
The stock price for Alvotech (NASDAQ: ALVO) is $4.5 last updated November 12, 2026 at 9:28 AM EST.
There are no upcoming dividends for Alvotech.
Alvotech does not have any upcoming earnings scheduled.
There is no upcoming split for Alvotech.
Alvotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to...
